CS MEDICA ("CS MEDICA" or "The Company") is pleased to announce the successful approval of several key proposals at its Extraordinary General Meeting (EGM) held on July 31, 2024.  The approved resolutions are as follows:

• Flemming Heegard was elected as the chairman of the meeting.

• The shareholders approved a capital increase of 317,000 shares at DKK 3.00 per share, without pre-emption rights for existing shareholders.
• The shares will be subscribed by Börsjakten AB or its related companies/persons, including its investor network.
• These shares will be used to offset remuneration for an Investor Relations (IR) Agreement with Börsjakten AB, amounting to SEK 1,450,000.
• The IR Agreement is set to run until July 11, 2025.

• The shareholders approved a cash capital increase of 499,200 shares at DKK 3.00 per share, without pre-emption rights for existing shareholders.
• The shares will be subscribed by Börsjakten AB or its related companies/persons, including its investor network.

• The shareholders approved the issuance of 3,000,000 new shares to CS MEDICA, with a nominal value of DKK 0.065 per share.
• These shares will be used to secure payment for Investor Relations (IR) related activities.
• The Company plans to engage various firms to enhance investor communication and engagement.
• Remuneration for these IR-related services will be offset through the issuance of the proposed 3,000,000 shares, with the number of shares calculated monthly based on the invoices from the service providers, using the share price at the end of each month.

The total number of votes as of the date of this Statement is 12,322,635, of which 71.8%, equal to 8,842,160 votes, were represented at the EGM. The resolutions were approved unanimously by all shareholders represented at the EGM.